|
Name |
Drechmerin G
|
| Molecular Formula | C27H33NO5 | |
| IUPAC Name* |
(1S,12S,17S,20S)-17-[(3S,4S)-4-hydroxy-2,2-dimethyl-5-oxooxolan-3-yl]oxy-1,20-dimethyl-3-azapentacyclo[10.8.0.02,10.04,9.015,20]icosa-2(10),4,6,8-tetraen-16-one
|
|
| SMILES |
C[C@]12CC[C@@H](C(=O)C1CC[C@@H]3[C@@]2(C4=C(C3)C5=CC=CC=C5N4)C)O[C@H]6[C@@H](C(=O)OC6(C)C)O
|
|
| InChI |
InChI=1S/C27H33NO5/c1-25(2)23(21(30)24(31)33-25)32-19-11-12-26(3)17(20(19)29)10-9-14-13-16-15-7-5-6-8-18(15)28-22(16)27(14,26)4/h5-8,14,17,19,21,23,28,30H,9-13H2,1-4H3/t14-,17?,19-,21-,23-,26-,27+/m0/s1
|
|
| InChIKey |
HSDRIGYXHXQJQM-GMEXRTGGSA-N
|
|
| Synonyms |
Drechmerin G
|
|
| CAS | NA | |
| PubChem CID | 139590917 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 451.6 | ALogp: | 4.2 |
| HBD: | 2 | HBA: | 5 |
| Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 88.6 | Aromatic Rings: | 6 |
| Heavy Atoms: | 33 | QED Weighted: | 0.657 |
| Caco-2 Permeability: | -5.034 | MDCK Permeability: | 0.00002600 |
| Pgp-inhibitor: | 0.907 | Pgp-substrate: | 0.085 |
| Human Intestinal Absorption (HIA): | 0.005 | 20% Bioavailability (F20%): | 0.006 |
| 30% Bioavailability (F30%): | 0.013 |
| Blood-Brain-Barrier Penetration (BBB): | 0.786 | Plasma Protein Binding (PPB): | 94.66% |
| Volume Distribution (VD): | 1.458 | Fu: | 3.21% |
| CYP1A2-inhibitor: | 0.086 | CYP1A2-substrate: | 0.856 |
| CYP2C19-inhibitor: | 0.191 | CYP2C19-substrate: | 0.734 |
| CYP2C9-inhibitor: | 0.217 | CYP2C9-substrate: | 0.16 |
| CYP2D6-inhibitor: | 0.023 | CYP2D6-substrate: | 0.277 |
| CYP3A4-inhibitor: | 0.688 | CYP3A4-substrate: | 0.644 |
| Clearance (CL): | 10.618 | Half-life (T1/2): | 0.071 |
| hERG Blockers: | 0.064 | Human Hepatotoxicity (H-HT): | 0.212 |
| Drug-inuced Liver Injury (DILI): | 0.638 | AMES Toxicity: | 0.016 |
| Rat Oral Acute Toxicity: | 0.974 | Maximum Recommended Daily Dose: | 0.885 |
| Skin Sensitization: | 0.208 | Carcinogencity: | 0.445 |
| Eye Corrosion: | 0.004 | Eye Irritation: | 0.016 |
| Respiratory Toxicity: | 0.977 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC002279 | ![]() |
0.584 | D0H4JM | ![]() |
0.315 | ||
| ENC003172 | ![]() |
0.570 | D0U7GP | ![]() |
0.285 | ||
| ENC005989 | ![]() |
0.570 | D01JGV | ![]() |
0.285 | ||
| ENC003876 | ![]() |
0.569 | D05MQK | ![]() |
0.266 | ||
| ENC005406 | ![]() |
0.557 | D0U3GL | ![]() |
0.264 | ||
| ENC002951 | ![]() |
0.553 | D0Q6NZ | ![]() |
0.254 | ||
| ENC005990 | ![]() |
0.547 | D08QKJ | ![]() |
0.250 | ||
| ENC005988 | ![]() |
0.546 | D0W7RJ | ![]() |
0.250 | ||
| ENC005405 | ![]() |
0.545 | D01XDL | ![]() |
0.250 | ||
| ENC004710 | ![]() |
0.534 | D04RLY | ![]() |
0.249 | ||